Specialty Overview

Best Hospitals for CAR T-Cell Therapy in Bengaluru, India

10 radiation oncology hospitals in our India network are listed in Bengaluru, accredited by NABH, JCI, NABL, ISO 9001, with 3,630 beds combined.

10
Hospitals Listed
1
City
4.5
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the radiation oncology hospitals in our directory offering CAR T-Cell Therapy in Bengaluru, India, including Narayana Health, Manipal Hospitals, Medicover Hospital, Bangalore, Gleneagles Hospitals, Bengaluru and others. Each listing links through to the hospital's full profile page.

Ask us about car t-cell therapy in Bengaluru, India

Share a few details and our care coordination team will get back to you with next steps.

Top Hospitals for CAR T-Cell Therapy in Bengaluru, India

Starting from$1,000

🇮🇳 Narayana Health

Bengaluru, India 4.8 (1750 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1750 reviewsAccredited by NABH1,000 beds
Specialties & Accreditation
CardiacPediatric SurgeryCancer
Accredited by NABH

Patients considering car t-cell therapy can be cared for by Narayana Health's care team in Bengaluru, India, from initial consultation through recovery. Narayana Health, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.

4.8/5
Rating
2000
Established
1,000
Beds
Bengaluru, India
Location
Manipal Hospitals
Starting from$1,000

🇮🇳 Manipal Hospitals

Bengaluru, India 4.7 (1450 reviews) 600 beds
Why consider this hospital?
4.7/5 rating from 1450 reviewsAccredited by JCI, NABH600 beds
Specialties & Accreditation
OrthopedicsNeurologyIVF
Accredited by JCI, NABH

Patients considering car t-cell therapy can be cared for by Manipal Hospitals's care team in Bengaluru, India, from initial consultation through recovery. Manipal Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.

4.7/5
Rating
1991
Established
600
Beds
Bengaluru, India
Location
Medicover Hospital, Bangalore
Starting from$1,000

🇮🇳 Medicover Hospital, Bangalore

Bengaluru, India 4.7 (68 reviews) 300 beds
Why consider this hospital?
4.7/5 rating from 68 reviewsAccredited by NABH300 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsUrology
Accredited by NABH

Patients considering car t-cell therapy can be cared for by Medicover Hospital, Bangalore's care team in Bengaluru, India, from initial consultation through recovery. Medicover Hospital, Bangalore, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.

4.7/5
Rating
2024
Established
300
Beds
Bengaluru, India
Location
Gleneagles Hospitals, Bengaluru
Starting from$1,000

🇮🇳 Gleneagles Hospitals, Bengaluru

Bengaluru, India 4.7 (142 reviews) 40 beds
Why consider this hospital?
4.7/5 rating from 142 reviewsAccredited by NABH40 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by NABH

Patients considering car t-cell therapy can be cared for by Gleneagles Hospitals, Bengaluru's care team in Bengaluru, India, from initial consultation through recovery. Gleneagles Hospitals, Bengaluru, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.

4.7/5
Rating
2017
Established
40
Beds
Bengaluru, India
Location
Manipal Hospital Malleshwaram (Northside)
Starting from$1,000

🇮🇳 Manipal Hospital Malleshwaram (Northside)

Malleshwaram, Bengaluru, India 4.6 (71 reviews) 83 beds
Why consider this hospital?
4.6/5 rating from 71 reviewsAccredited by NABH, NABL, ISO 900183 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurosciencesGastroenterologyOncology
Accredited by NABH, NABL, ISO 9001

Patients considering car t-cell therapy can be cared for by Manipal Hospital Malleshwaram (Northside)'s care team in Malleshwaram, Bengaluru, India, from initial consultation through recovery. Manipal Hospital Malleshwaram (Northside), accredited by NABH, NABL, ISO 9001, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.

4.6/5
Rating
1993
Established
83
Beds
Malleshwaram, Bengaluru, India
Location
Manipal Hospital, Old Airport Road
Starting from$1,000

🇮🇳 Manipal Hospital, Old Airport Road

Bangalore, India 4.5 (87 reviews) 680 beds
Why consider this hospital?
4.5/5 rating from 87 reviewsAccredited by NABH, JCI680 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantOncologyOrthopedics
Accredited by NABH, JCI

Patients considering car t-cell therapy can be cared for by Manipal Hospital, Old Airport Road's care team in Bangalore, India, from initial consultation through recovery. Manipal Hospital, Old Airport Road, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.

4.5/5
Rating
1991
Established
680
Beds
Bangalore, India
Location
Manipal Hospital Yeshwanthpur (Columbia Asia)
Starting from$1,000

🇮🇳 Manipal Hospital Yeshwanthpur (Columbia Asia)

Yeshwanthpur, Bangalore, India 4.5 (98 reviews) 168 beds
Why consider this hospital?
4.5/5 rating from 98 reviewsAccredited by NABH, JCI168 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurosciencesOncologyGastroenterology
Accredited by NABH, JCI

Patients considering car t-cell therapy can be cared for by Manipal Hospital Yeshwanthpur (Columbia Asia)'s care team in Yeshwanthpur, Bangalore, India, from initial consultation through recovery. Manipal Hospital Yeshwanthpur (Columbia Asia), accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.

4.5/5
Rating
2008
Established
168
Beds
Yeshwanthpur, Bangalore, India
Location
Manipal Hospital Millers Road (Vikram Hospital)
Starting from$1,000

🇮🇳 Manipal Hospital Millers Road (Vikram Hospital)

Millers Road, Bangalore, India 4.4 (74 reviews) 225 beds
Why consider this hospital?
4.4/5 rating from 74 reviewsAccredited by NABH225 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurosciencesOncologyGastroenterology
Accredited by NABH

Patients considering car t-cell therapy can be cared for by Manipal Hospital Millers Road (Vikram Hospital)'s care team in Millers Road, Bangalore, India, from initial consultation through recovery. Manipal Hospital Millers Road (Vikram Hospital), accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.

4.4/5
Rating
2009
Established
225
Beds
Millers Road, Bangalore, India
Location
Apollo Hospital, Bannerghatta Road
Starting from$1,000

🇮🇳 Apollo Hospital, Bannerghatta Road

Bangalore, India 4.2 (25 reviews) 250 beds
Why consider this hospital?
4.2/5 rating from 25 reviewsAccredited by JCI, NABH250 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering car t-cell therapy can be cared for by Apollo Hospital, Bannerghatta Road's care team in Bangalore, India, from initial consultation through recovery. Apollo Hospital, Bannerghatta Road, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.

4.2/5
Rating
2007
Established
250
Beds
Bangalore, India
Location
Fortis Hospital, Bannerghatta Road
Starting from$1,000

🇮🇳 Fortis Hospital, Bannerghatta Road

Bangalore, India 4.2 (58 reviews) 284 beds
Why consider this hospital?
4.2/5 rating from 58 reviewsAccredited by NABH, JCI284 beds
Specialties & Accreditation
Multi SpecialtyCardiac SurgeryNeurosciencesOrthopedicsCancer
Accredited by NABH, JCI

Patients considering car t-cell therapy can be cared for by Fortis Hospital, Bannerghatta Road's care team in Bangalore, India, from initial consultation through recovery. Fortis Hospital, Bannerghatta Road, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.

4.2/5
Rating
2006
Established
284
Beds
Bangalore, India
Location

Top Radiation Oncology Doctors in Bengaluru, India

Dr. Anitha Gopinath Featured

Dr. Anitha Gopinath

MBBS, MD — Radiation Oncology, DNB — Radiation Oncology
Senior Consultant — Radiation Oncology · Radiation Oncologist
Apollo Hospitals, Bannerghatta Road Bengaluru, India18+ Years experience
Why consider this doctor?
  • 18+ years of experience in Radiation Oncologist
  • Senior Consultant, Radiation Oncology — Apollo Hospitals, Bannerghatta Road, Bengaluru — Present
  • Consultant, Radiation Oncology — Apollo Specialty, Chennai — Prior to Bengaluru posting
Expertise & Procedures
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Image-Guided Radiation Therapy (IGRT)
  • 3D Conformal Radiotherapy
  • Stereotactic Body Radiation Therapy (SBRT)
  • Stereotactic Radiosurgery (SRS)
View all procedures →
Radiation Oncologist Experience: 18+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta Road
Dr. Kalyani Premchandra

Dr. Kalyani Premchandra

MBBS, MD, DNB
Consultant — Radiation Oncology · Radiation Oncologist
Apollo Hospitals, Bannerghatta Road Bengaluru, India13+ Years experience
Why consider this doctor?
  • 13+ years of experience in Radiation Oncologist
  • Consultant, Radiation Oncology – Apollo Hospitals, Bannerghatta Road, Bengaluru, India
  • Clinical expertise spanning 13+ years in comprehensive oncology and radiation therapy across multiple tumor types
Expertise & Procedures
  • CyberKnife Radiosurgery
  • Intensity-Modulated Radiation Therapy (IMRT)
  • 3D Conformal Radiotherapy
  • Stereotactic Body Radiation Therapy (SBRT)
  • Image-Guided Radiation Therapy (IGRT)
View all procedures →
Radiation Oncologist Experience: 13+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta Road
Dr. M Vinay Ural

Dr. M Vinay Ural

MBBS, MD (Radiation Oncology), DMRT, DNB (Radiation Oncology), Clinical Training — Image-Guided Radiotherapy/IMRT
Senior Consultant — Radiation Oncology · Radiation Oncologist
Apollo Hospitals, Bannerghatta Road Bengaluru, India22+ Years experience
Why consider this doctor?
  • 22+ years of experience in Radiation Oncologist
  • Senior Consultant, Radiation Oncology — Apollo Hospitals, Bannerghatta Road, Bengaluru, Present
  • Specialist Radiation Oncologist — Apollo Hospitals, Bengaluru,
Expertise & Procedures
  • Stereotactic Radiosurgery (SRS) for brain lesions
  • Stereotactic Body Radiation Therapy (SBRT)
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Image-Guided Radiation Therapy (IGRT)
  • 3D Conformal Radiotherapy
View all procedures →
Radiation Oncologist Experience: 22+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta Road
Dr. Mathangi J

Dr. Mathangi J

MBBS, DMRT, DNB
Senior Consultant and In-Charge — Radiation Oncology · Radiation Oncologist
Gleneagles Hospitals Bengaluru, India19+ Years experience
Why consider this doctor?
  • 19+ years of experience in Radiation Oncologist
  • Senior Consultant and In-Charge, Radiation Oncology Department, Gleneagles Hospitals, Bengaluru
  • 19+ years of specialized clinical practice in radiation oncology and comprehensive cancer care
Expertise & Procedures
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Brachytherapy (Internal Radiation Therapy)
  • Stereotactic Body Radiation Therapy (SBRT)
  • Stereotactic Radiosurgery (SRS)
  • CyberKnife Radiosurgery
View all procedures →
Radiation Oncologist Experience: 19+ YearsHospital Affiliation: Gleneagles Hospitals
Dr. Natarajan V

Dr. Natarajan V

MBBS, DNB (Radiation Oncology)
Consultant — Radiation Oncology · Radiation Oncologist
Apollo Hospitals, Bannerghatta Road Bengaluru, India11+ Years experience
Why consider this doctor?
  • 11+ years of experience in Radiation Oncologist
  • Consultant, Radiation Oncology — Apollo Hospitals, Bannerghatta Road, Bengaluru, India
  • Life Member, Association of Radiation Oncologists of India
Expertise & Procedures
  • 3D Conformal Radiotherapy (3D-CRT)
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Image-Guided Radiation Therapy (IGRT)
  • Stereotactic Body Radiation Therapy (SBRT)
  • Stereotactic Radiosurgery (SRS)
View all procedures →
Radiation Oncologist Experience: 11+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta Road
Dr. Rajeev G

Dr. Rajeev G

MBBS, MS, MHA
Consultant — Radiation Oncology · Radiation Oncologist
Apollo Hospitals, Bannerghatta Road Bengaluru, India15+ Years experience
Why consider this doctor?
  • 15+ years of experience in Radiation Oncologist
  • Consultant — Radiation Oncology, Apollo Hospitals, Bannerghatta Road, Bengaluru — Present
  • Senior Resident, Radiation Oncology,
Expertise & Procedures
  • Intensity-Modulated Radiation Therapy (IMRT)
  • 3D Conformal Radiotherapy
  • Image-Guided Radiation Therapy (IGRT)
  • Stereotactic Radiosurgery (SRS)
  • Stereotactic Body Radiation Therapy (SBRT)
View all procedures →
Radiation Oncologist Experience: 15+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta Road
Our Methodology

How we selected these hospitals

A hospital appears on this page when Radiation Oncology is among its listed specialties and it is located in Bengaluru, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for CAR T-Cell Therapy in Bengaluru, India?

Choosing the right hospital for car t-cell therapy is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include radiation oncology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding CAR T-Cell Therapy

CAR T-Cell Therapy (Chimeric Antigen Receptor T-Cell Therapy) is a groundbreaking, personalized immunotherapy that genetically engineers a patient's own T-lymphocytes to recognize and destroy cancer cells with precision unmatched by conventional chemotherapy or radiation.

21–35 days (inpatient monitoring phase: apheresis, conditioning chemotherapy, infusion, and acute toxicity management)
Hospital Stay
8–14 weeks (minimum 60–90 days post-infusion before international air travel is considered safe, subject to treating physician clearance, ECHO, and full blood count recovery)
Total Stay in Country (Fit-to-Fly)
40–81% (varies by indication: ~81% ORR in pediatric B-ALL; 52–83% ORR in DLBCL; 65–85% in multiple myeloma with newer BCMA-targeted constructs)
Success Rate

Clinical Overview

  • CAR T-Cell Therapy represents a paradigm shift in the treatment of hematological malignancies and is increasingly being explored in solid tumors.
  • The process begins with leukapheresis—collecting a patient's T-lymphocytes from peripheral blood—which are then sent to a Good Manufacturing Practice (GMP)-certified laboratory where they are retrovirally or lentivirally transduced to express a chimeric antigen receptor on their surface.
  • This receptor is engineered to bind a specific tumor antigen (most commonly CD19 for B-cell malignancies, BCMA for multiple myeloma, or CD22 as an emerging target) with high affinity, bypassing the need for MHC-mediated antigen presentation that cancer cells frequently downregulate to evade immunity.
Full details →

Who is a Candidate?

  • ELIGIBLE DIAGNOSES: Relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after ≥2 prior lines of systemic therapy; R/R follicular lymphoma (grade 3B); R/R mantle cell lymphoma; R/R B-cell acute lymphoblastic leukemia (B-ALL) in pediatric and young adult patients (up to age 25); R/R multiple myeloma after ≥4 prior lines (including a proteasome inhibitor, immunomodulatory agent, and anti-CD38 antibody).
  • PERFORMANCE STATUS: ECOG performance status 0–2; Karnofsky Performance Score ≥60%.
  • ORGAN FUNCTION REQUIREMENTS (ELIGIBILITY THRESHOLD): Creatinine clearance ≥45 mL/min (CKD-EPI formula); ALT/AST ≤5× ULN; total bilirubin ≤2× ULN; LVEF ≥50% confirmed on 2D Echocardiography (ECHO) or MUGA scan; no active Grade ≥3 pulmonary dysfunction (baseline O₂ saturation ≥92% on room air).
  • REQUIRED DIAGNOSTIC WORKUP BEFORE TRAVEL: Whole-body PET-CT scan (FDG) within 4 weeks; bilateral bone marrow biopsy with flow cytometry and cytogenetics; complete blood count with differential and comprehensive metabolic panel; serum protein electrophoresis and immunofixation (for myeloma); HLA typing (for allogeneic considerations); infectious disease panel (HIV Ag/Ab, Hepatitis B surface Ag and core Ab, Hepatitis C Ab, CMV IgG/IgM, EBV VCA IgG, quantitative CMV PCR); cardiac ECHO; pulmonary function tests (FEV1, DLCO); MRI brain (to rule out CNS disease or ICANS risk factors); prior treatment records including all chemotherapy regimens, radiation fields, stem cell transplant history.
  • +2 more

Treatment Options & Approaches

  • CAR T-Cell Therapy is not a single procedure but a multi-step biological manufacturing and clinical delivery process.
  • The following approaches and product categories are available at partner centers in India and the UAE:

Recovery

  • PHASE 1 — PRE-TRAVEL CONSULTATION (2–4 weeks before departure):

Risks to be aware of

  • CAR T-Cell Therapy carries a distinct and serious toxicity profile that patients and caregivers must understand thoroughly before initiating treatment.
  • Cytokine Release Syndrome (CRS) is the most common acute toxicity, occurring in 57–93% of patients depending on the product and disease burden; Grade 3–4 CRS (severe hypotension, Grade 3+ hypoxia requiring high-flow oxygen or mechanical ventilation) occurs in 13–22% of cases and requires ICU-level management including vasopressors and tocilizumab.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated, end-to-end logistics infrastructure designed specifically for the complexity of CAR T-Cell therapy, where timing, proximity to the treatment center, and rapid access to emergency care during the post-infusion monitoring period are non-negotiable.

Cost Range for Related Procedures

Cancer Surgery$4,000$15,000
Chemotherapy$1,000$4,000
Radiation Therapy$3,500$10,000
Get a personalised estimate with our cost calculator →

Common questions about CAR T-Cell Therapy

What is the cost of CAR T-Cell Therapy in India vs the UAE?
The all-inclusive cost of CAR T-Cell Therapy in India ranges from approximately $40,000 to $100,000 USD—making it one of the most cost-effective destinations globally for this treatment. This range covers leukapheresis, GMP-certified cell manufacturing (including India's indigenously approved CD19 CAR T-Cell product, which is significantly less expensive than imported commercial products like Kymriah or Yescarta), lymphodepletion chemotherapy, the inpatient hospital stay during infusion and acute toxicity management, tocilizumab administration for CRS treatment, standard outpatient follow-up visits through Day 60, and nursing care. In the UAE (Dubai or Abu Dhabi), the equivalent all-inclusive treatment cost ranges from approximately $90,000 to $180,000 USD—reflecting the use of internationally imported FDA/EMA-approved commercial CAR T-cell products, premium inpatient infrastructure, and the UAE's higher overall healthcare operational costs. By comparison, the same treatment in the United States costs $450,000–$700,000+ when hospital, physician, and product fees are combined. GAF Healthcare's case managers provide a detailed, itemized cost estimate specific to each patient's diagnosis, selected product, and clinical risk profile before any financial commitment is made.
How long do I need to stay in the country before I am fit to fly home after CAR T-Cell Therapy?
International patients undergoing CAR T-Cell Therapy must plan for a minimum stay of 8 to 14 weeks (approximately 60–100 days) in the treatment country before they are medically cleared for international air travel. This extended stay is a non-negotiable medical requirement, not a logistical preference. The mandatory post-infusion monitoring period is driven by several critical clinical factors: Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) can onset or escalate up to 14 days post-infusion and require immediate hospital-level intervention. Prolonged cytopenias (low neutrophil and platelet counts) typically persist for 4–8 weeks and represent a serious infection and bleeding risk during long-haul flights and in transit. Response assessment PET-CT scans are performed at Day 28–30 and Day 90 per international Lugano criteria, and treating physicians require at least the Day 28 scan before making a fit-to-fly determination. Blood counts, ECHO confirmation of cardiac function, and absence of active infection must all be verified before travel clearance is issued. Patients with severe or prolonged cytopenias, hypogammaglobulinemia requiring IVIG infusions, or delayed ICANS resolution may require up to 16 weeks before travel is safe. GAF Healthcare arranges comfortable serviced apartment accommodation for the patient and one attendant for the full duration of the stay, at pre-negotiated rates in close proximity to the treatment hospital.
What is the success rate of CAR T-Cell Therapy?
The success rate of CAR T-Cell Therapy varies significantly by the specific cancer diagnosis, the patient's prior treatment history, and the CAR T-cell product used. In relapsed/refractory diffuse large B-cell lymphoma (DLBCL)—the most common indication—axicabtagene ciloleucel (Yescarta) achieves an overall response rate (ORR) of 72–83% and a complete response (CR) rate of 52–58%, with approximately 40% of patients maintaining durable CR beyond 2 years (considered functionally curative). Lisocabtagene maraleucel (Breyanzi) demonstrates similar efficacy with a more favorable toxicity profile (lower Grade ≥3 ICANS rates). In pediatric and young adult B-cell Acute Lymphoblastic Leukemia (B-ALL), tisagenlecleucel (Kymriah) achieves an ORR of 81% with 60% complete remission at 12 months—remarkable outcomes in a population with otherwise limited options. In relapsed/refractory multiple myeloma, ciltacabtagene autoleucel (Carvykti) achieves an ORR of 97% with a 78% stringent complete response rate in heavily pre-treated patients, though long-term follow-up data are still maturing. For follicular lymphoma, axicabtagene ciloleucel achieves an ORR of 94% and CR of 79%. It is important to understand that 'success' in CAR T-Cell Therapy encompasses complete response rates, progression-free survival, and durable remission—not all responders achieve cure, and disease relapse, often via antigen escape, occurs in 30–60% of initial responders within 2 years. GAF Healthcare's partner oncologists provide individualized prognosis estimates based on the patient's specific pathology, molecular markers, prior therapy lines, and performance status before treatment initiation.

How GAF Healthcare Assists in Choosing the Best Hospital for CAR T-Cell Therapy in Bengaluru, India

Discover the Top Hospitals for CAR T-Cell Therapy in Bengaluru, India

This page lists 10 accredited radiation oncology hospitals in Bengaluru, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Patient Success Story

Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India
Common Questions

Frequently asked questions about car t-cell therapy in Bengaluru, India

How many radiation oncology hospitals are listed in Bengaluru, India?
10 hospitals in our Bengaluru, India directory are currently listed for radiation oncology including CAR T-Cell Therapy.
How do you choose which hospitals to list?
A hospital appears on this page when Radiation Oncology is among its listed specialties and it is located in Bengaluru, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there radiation oncology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including NABH, JCI, NABL, ISO 9001 — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for car t-cell therapy?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about car t-cell therapy in Bengaluru, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for car t-cell therapy in Bengaluru, India.

Contact us to report an inaccuracy on this page.